On January 26, 2017, Thépenier Pharma and Orléans Cosmetics joined forces.
This merger is part of a drive to accelerate the globalization strategy of the Nippon Shikizai group, of which Thépenier Pharma is a subsidiary, which is conditioned in particular by the strengthening of its presence in Europe and its long-standing roots in the French tradition of luxury cosmetics.
Highly beneficial synergy effects are expected from this strategic acquisition. In addition to its long-standing activity in the manufacture of liquid and pasty medicines, this operation will enable Thépenier Pharma to extend its know-how in the make-up sector, and to offer, like its parent company on the Asian and North American markets, a complete range of products and services designed and manufactured in France to players in the cosmetics industry operating in Europe: skincare (emulsions, lotions, gels), suncare products, cosmetic powders, hot-cast products, the manufacture of complex make-up palettes and fragrance derivatives.
The creative potential in make-up and skincare products of the Nippon Shikizai group, recognized for the innovative character, quality and sensoriality of its textures by the major international players in the luxury sector, is enriched by the capacity of the Orléans Cosmetics R&D laboratory to develop products recognized for their high standards and competitiveness.
Last but not least, this merger will optimize the industrial organization of the Group's activities in Europe, enabling each site to refocus on its key know-how and to continuously develop the quality and originality of the products it offers by strengthening and segmenting the R&D teams of each structure.
